KARYOPHARM THERAPEUTICS INC's ticker is KPTI and the CUSIP is 48576U106. A total of 141 filers reported holding KARYOPHARM THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is 0.42 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $415,487 | -39.5% | 310,065 | -19.2% | 0.07% | -42.3% |
| Q2 2023 | $687,088 | +54.5% | 383,848 | +193.4% | 0.12% | +30.9% |
| Q4 2022 | $444,778 | +101.3% | 130,817 | +222.7% | 0.09% | +70.9% |
| Q3 2022 | $221,000 | -5.2% | 40,541 | -21.4% | 0.06% | -42.1% |
| Q2 2022 | $233,000 | +119.8% | 51,606 | +257.7% | 0.10% | +106.5% |
| Q1 2022 | $106,000 | +26.2% | 14,429 | +10.6% | 0.05% | -4.2% |
| Q4 2021 | $84,000 | -11.6% | 13,051 | -19.8% | 0.05% | +50.0% |
| Q3 2021 | $95,000 | – | 16,272 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| AIGH Capital Management LLC | 1,773,474 | $2,376,456 | 1.12% |
| AlphaCentric Advisors LLC | 1,125,000 | $1,507,500 | 0.86% |
| Tejara Capital Ltd | 1,077,388 | $1,443,700 | 0.82% |
| Palo Alto Investors LP | 5,675,876 | $7,605,674 | 0.72% |
| Birchview Capital, LP | 571,832 | $766,255 | 0.65% |
| Altium Capital Management LP | 740,000 | $991,600 | 0.52% |
| Avidity Partners Management LP | 8,298,570 | $11,120,084 | 0.45% |
| Worth Venture Partners, LLC | 445,981 | $597,615 | 0.36% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 561,955 | $753,020 | 0.23% |
| DAFNA Capital Management LLC | 192,678 | $258,189 | 0.08% |